The IGF system

Acta Diabetologica

Volumn 48, Issue 1, 2011, Pages 1-9

  Annunziata, Marta ^a   Granata, Riccarda ^a   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cell proliferation; IGF system; Insulin analogs

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

BINDING AFFINITY; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; GLUCOSE METABOLISM; HEART PROTECTION; HUMAN; NEUROPROTECTION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CELL PROLIFERATION; HUMANS; INSULIN; MITOGENS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 79953321008     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0227-z     Document Type: Review

References (118)

1. D Le Roith 2003 The insulin-like growth factor system Exp Diabesity Res 4 4 205 212 9DM2KUX7VXW0N7H6[pii]10.1155/EDR.2003.205 14668044 (Pubitemid 38035562)
2. M Federici O Porzio L Zucaro A Fusco P Borboni D Lauro G Sesti 1997 Distribution of insulin/insulin-like growth factor-i hybrid receptors in human tissues Mol Cell Endocrinol 129 2 121 126 S0303-7207(97)04050-1[pii] 9202395 1:CAS:528:DyaK2sXjvFymt7w%3D (Pubitemid 27281527)
3. WD Salmon Jr WH Daughaday 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro J Lab Clin Med 49 6 825 836 13429201 1:CAS:528:DyaG2sXhtVSms74%3D
4. WH Daughaday K Hall MS Raben WD Salmon Jr JL van den Brande JJ van Wyk 1972 Somatomedin: proposed designation for sulphation factor Nature 235 5333 107 4550398 1:CAS:528:DyaE38XktVSrtLc%3D
5. ER Froesch H Buergi EB Ramseier P Bally A Labhart 1963 Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity J Clin Invest 42 1816 1834 10.1172/JCI104866 14083170 1:CAS:528:DyaF2cXks12isA%3D%3D
6. TL Blundell S Bedarkar E Rinderknecht RE Humbel 1978 Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding Proc Natl Acad Sci USA 75 1 180 184 272633 1:CAS:528: DyaE1cXhtFKmtb0%3D (Pubitemid 8290474)
7. E Rinderknecht RE Humbel 1978 The amino acid sequence of human insulin-like growth factor i and its structural homology with proinsulin J Biol Chem 253 8 2769 2776 632300 1:CAS:528:DyaE1cXktlyhu7s%3D (Pubitemid 8326483)
8. DG Klapper ME Svoboda JJ Van Wyk 1983 Sequence analysis of somatomedin-c: confirmation of identity with insulin-like growth factor i Endocrinology 112 6 2215 2217 6343062 1:CAS:528:DyaL3sXksVyjsL8%3D (Pubitemid 13048678)
9. WH Daughaday K Hall WD Salmon Jr JL Van den Brande JJ Van Wyk 1987 On the nomenclature of the somatomedins and insulin-like growth factors J Clin Endocrinol Metab 65 5 1075 1076 3667879 1:CAS:528:DyaL1cXjtF2qtw%3D%3D
10. DR Clemmons 2006 Involvement of insulin-like growth factor-i in the control of glucose homeostasis Curr Opin Pharmacol 6 6 620 625 S1471-4892(06)00167-6[pii]10.1016/j.coph.2006.08.006 17030015 1:CAS:528:DC%2BD28XhtFKmt7fL (Pubitemid 44752640)
11. SA Kaplan P Cohen 2007 The somatomedin hypothesis 2007: 50 years later J Clin Endocrinol Metab 92 12 4529 4535 jc.2007-0526[pii]10.1210/jc.2007-0526 17986643 1:CAS:528:DC%2BD1cXmslWhtro%3D (Pubitemid 350223421)
12. JE Brissenden A Ullrich U Francke 1984 Human chromosomal mapping of genes for insulin-like growth factors i and ii and epidermal growth factor Nature 310 5980 781 784 6382023 1:CAS:528:DyaL2cXmtVGitLc%3D (Pubitemid 14057658)
13. JV Tricoli LB Rall J Scott GI Bell TB Shows 1984 Localization of insulin-like growth factor genes to human chromosomes 11 and 12 Nature 310 5980 784 786 6382024 1:CAS:528:DyaL2cXmtVGitb4%3D (Pubitemid 14057659)
14. P Rotwein KM Pollock DK Didier GG Krivi 1986 Organization and sequence of the human insulin-like growth factor i gene. Alternative RNA processing produces two insulin-like growth factor i precursor peptides J Biol Chem 261 11 4828 4832 2937782 1:CAS:528:DyaL28Xit1SjsLY%3D (Pubitemid 17204268)
15. PJ Smith EL Spurrell J Coakley CJ Hinds RJ Ross AR Krainer SL Chew 2002 An exonic splicing enhancer in human igf-i pre-mrna mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor Endocrinology 143 1 146 154 11751603 1:CAS:528: DC%2BD38XjtVOruw%3D%3D (Pubitemid 34056413)
16. JS Sussenbach PH Steenbergh P Holthuizen 1992 Structure and expression of the human insulin-like growth factor genes Growth Regul 2 1 1 9 1486331 1:CAS:528:DyaK2MXhs1eisg%3D%3D
17. CH Li D Yamashiro D Gospodarowicz SL Kaplan G Van Vliet 1983 Total synthesis of insulin-like growth factor i (somatomedin c) Proc Natl Acad Sci USA 80 8 2216 2220 6572973 1:CAS:528:DyaL3sXktFKlt7Y%3D (Pubitemid 13097163)
18. TL Blundell S Bedarkar RE Humbel 1983 Tertiary structures, receptor binding, and antigenicity of insulin like growth factors Fed Proc 42 9 2592 2597 6189745 1:CAS:528:DyaL3sXksVyjsLg%3D (Pubitemid 13040973)
19. DR Clemmons 1997 Insulin-like growth factor binding proteins and their role in controlling igf actions Cytokine Growth Factor Rev 8 1 45 62 S1359610196000536[pii] 9174662 1:CAS:528:DyaK2sXktFShsbs%3D (Pubitemid 27214688)
20. RC Baxter JL Martin 1989 Binding proteins for the insulin-like growth factors: structure, regulation and function Prog Growth Factor Res 1 1 49 68 2485012 1:CAS:528:DyaL1MXit1Gmurg%3D
21. SM Firth RC Baxter 2002 Cellular actions of the insulin-like growth factor binding proteins Endocr Rev 23 6 824 854 12466191 1:CAS:528: DC%2BD38XpvVSntb8%3D (Pubitemid 35454590)
22. R Rapp A Deger W Blum R Koch U Weber 1988 Characterization of the protein which binds insulin-like growth factor in human serum Eur J Biochem 172 2 421 425 2450744 1:CAS:528:DyaL1cXhs1aitr4%3D (Pubitemid 18071111)
23. D Le Roith C Bondy S Yakar JL Liu A Butler 2001 The somatomedin hypothesis: 2001 Endocr Rev 22 1 53 74 11159816 1:CAS:528:DC%2BD3MXhsFait7w%3D (Pubitemid 32187803)
24. HS Kim AR Ingermann J Tsubaki SM Twigg GE Walker Y Oh 2004 Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in mcf-7 human breast cancer cells Cancer Res 64 6 2229 2237 15026367 1:CAS:528:DC%2BD2cXitFCgu7c%3D (Pubitemid 38339477)
25. CM Perks PV Newcomb MR Norman JM Holly 1999 Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells J Mol Endocrinol 22 2 141 150 10194517 1:CAS:528:DyaK1MXktVChsL4%3D (Pubitemid 29193102)
26. R Granata L Trovato G Garbarino M Taliano R Ponti G Sala R Ghidoni E Ghigo 2004 Dual effects of igfbp-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways FASEB J 18 12 1456 1458 10.1096/fj.04-1618fje04-1618fje[pii] 15247143 1:CAS:528:DC%2BD2cXntlKktb4%3D (Pubitemid 39561613)
27. PM Yamada KW Lee 2009 Perspectives in mammalian igfbp-3 biology: local vs. systemic action Am J Physiol Cell Physiol 296 5 C954 C976 00598.2008[pii]10.1152/ajpcell.00598.2008 19279229 1:CAS:528: DC%2BD1MXlvFahtbs%3D
28. DR Clemmons 2009 Role of igf-i in skeletal muscle mass maintenance Trends Endocrinol Metab 20 7 349 356 S1043-2760(09)00090-3[pii]10.1016/j.tem.2009.04. 002 19729319 1:CAS:528:DC%2BD1MXhtFantbfM
29. CH Heldin A Ostman 1996 Ligand-induced dimerization of growth factor receptors: variations on the theme Cytokine Growth Factor Rev 7 1 3 10 1359610196000020[pii] 8864349 1:CAS:528:DyaK28XkvVWltrs%3D (Pubitemid 27202661)
30. PD House MJ Weidemann 1970 Characterization of an [125 i]-insulin binding plasma membrane fraction from rat liver Biochem Biophys Res Commun 41 3 541 548 0006-291X(70)90046-X[pii] 4320281 1:CAS:528:DyaE3MXisl2ltw%3D%3D
31. P Freychet J Roth DM Neville Jr 1971 Insulin receptors in the liver: specific binding of (125 i)insulin to the plasma membrane and its relation to insulin bioactivity Proc Natl Acad Sci USA 68 8 1833 1837 4331561 1:CAS:528:DyaE3MXlsVyis7c%3D
32. P Cuatrecasas 1971 Insulin-receptor interactions in adipose tissue cells: direct measurement and properties Proc Natl Acad Sci USA 68 6 1264 1268 5288373 1:CAS:528:DyaE3MXkslWqtr4%3D
33. S Gammeltoft J Gliemann 1973 Binding and degradation of 125i-labelled insulin by isolated rat fat cells Biochim Biophys Acta 320 1 16 32 0304-4165(73)90161-X[pii] 4748361 1:CAS:528:DyaE3sXltFentLY%3D
34. CC Yip CW Yeung ML Moule 1980 Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations Biochemistry 19 1 70 76 6986166 1:CAS:528:DyaL3cXlt1aluw%3D%3D (Pubitemid 10154187)
35. J Massague MP Czech 1982 The subunit structures of two distinct receptors for insulin-like growth factors i and ii and their relationship to the insulin receptor J Biol Chem 257 9 5038 5045 6279656 1:CAS:528:DyaL38XitFWlsL4%3D (Pubitemid 12063194)
36. MA Shia PF Pilch 1983 The beta subunit of the insulin receptor is an insulin-activated protein kinase Biochemistry 22 4 717 721 6340724 1:CAS:528:DyaL3sXmsFyksQ%3D%3D (Pubitemid 13134035)
37. RA Roth DJ Cassell 1983 Insulin receptor: evidence that it is a protein kinase Science 219 4582 299 301 6849137 1:CAS:528:DyaL3sXmsF2jsQ%3D%3D (Pubitemid 13222311)
38. M Kasuga Y Fujita-Yamaguchi DL Blithe CR Kahn 1983 Tyrosine-specific protein kinase activity is associated with the purified insulin receptor Proc Natl Acad Sci USA 80 8 2137 2141 6188161 1:CAS:528:DyaL3sXhvFaitLw%3D (Pubitemid 13097150)
39. M Kasuga Y Fujita-Yamaguchi DL Blithe MF White CR Kahn 1983 Characterization of the insulin receptor kinase purified from human placental membranes J Biol Chem 258 18 10973 10980 6309826 1:CAS:528:DyaL3sXlvFSgtrs%3D (Pubitemid 13021262)
40. M Pashmforoush SJ Chan DF Steiner 1996 Structure and expression of the insulin-like peptide receptor from amphioxus Mol Endocrinol 10 7 857 866 8813726 1:CAS:528:DyaK28XktVagtro%3D (Pubitemid 26234624)
41. K Megyesi CR Kahn J Roth DM Neville Jr SP Nissley RE Humbel ER Froesch 1975 The nsila-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor J Biol Chem 250 23 8990 8996 391 1:CAS:528:DyaE28XlsVeltQ%3D%3D
42. RN Marshall LE Underwood SJ Voina DB Foushee JJ Van Wyk 1974 Characterization of the insulin and somatomedin-c receptors in human placental cell membranes J Clin Endocrinol Metab 39 2 283 292 4370626 1:CAS:528: DyaE2MXis1Wrtw%3D%3D
43. B Bhaumick RM Bala MD Hollenberg 1981 Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor Proc Natl Acad Sci USA 78 7 4279 4283 6270667 1:CAS:528:DyaL3MXltV2jtLw%3D (Pubitemid 11010315)
44. SD Chernausek S Jacobs JJ Van Wyk 1981 Structural similarities between human receptors for somatomedin c and insulin: analysis by affinity labeling Biochemistry 20 26 7345 7350 6275879 1:CAS:528:DyaL38XhtFCq (Pubitemid 12189279)
45. S Jacobs FC Kull Jr HS Earp ME Svoboda JJ Van Wyk P Cuatrecasas 1983 Somatomedin-c stimulates the phosphorylation of the beta-subunit of its own receptor J Biol Chem 258 16 9581 9584 6309774 1:CAS:528:DyaL3sXltFKrtbk%3D (Pubitemid 13049086)
46. JB Rubin MA Shia PF Pilch 1983 Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor i Nature 305 5933 438 440 6312321 1:CAS:528:DyaL3sXlslSgtLc%3D (Pubitemid 14225152)
47. A Ullrich A Gray AW Tam T Yang-Feng M Tsubokawa C Collins W Henzel T Le Bon S Kathuria E Chen, et al. 1986 Insulin-like growth factor i receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity EMBO J 5 10 2503 2512 2877871 1:CAS:528:DyaL2sXhtl2isw%3D%3D
48. S Jacobs FC Kull Jr P Cuatrecasas 1983 Monensin blocks the maturation of receptors for insulin and somatomedin c: identification of receptor precursors Proc Natl Acad Sci USA 80 5 1228 1231 6298786 1:CAS:528:DyaL3sXhsFGnsb8%3D (Pubitemid 13082787)
49. G Steele-Perkins J Turner JC Edman J Hari SB Pierce C Stover WJ Rutter RA Roth 1988 Expression and characterization of a functional human insulin-like growth factor i receptor J Biol Chem 263 23 11486 11492 2969892 1:CAS:528:DyaL1cXltVGmsLw%3D
50. N Sasaki RW Rees-Jones Y Zick SP Nissley MM Rechler 1985 Characterization of insulin-like growth factor i-stimulated tyrosine kinase activity associated with the beta-subunit of type i insulin-like growth factor receptors of rat liver cells J Biol Chem 260 17 9793 9804 2991263 1:CAS:528:DyaL2MXltVSrsbs%3D (Pubitemid 15013038)
51. MA Soos K Siddle 1989 Immunological relationships between receptors for insulin and insulin-like growth factor i. Evidence for structural heterogeneity of insulin-like growth factor i receptors involving hybrids with insulin receptors Biochem J 263 2 553 563 2480779 1:CAS:528:DyaL1MXlvV2rtLY%3D (Pubitemid 19254161)
52. MA Soos CE Field K Siddle 1993 Purified hybrid insulin/insulin-like growth factor-i receptors bind insulin-like growth factor-i, but not insulin, with high affinity Biochem J 290 Pt 2 419 426 8452530 1:CAS:528: DyaK3sXhvVeqtLw%3D (Pubitemid 23094937)
53. A Belfiore F Frasca G Pandini L Sciacca R Vigneri 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr Rev 30 6 586 623 er.2008-0047[pii]10.1210/er.2008- 0047 19752219 1:CAS:528:DC%2BD1MXhsVyhsrbK
54. GR Hankins AT De Souza RC Bentley MR Patel JR Marks JD Iglehart RL Jirtle 1996 M6p/igf2 receptor: a candidate breast tumor suppressor gene Oncogene 12 9 2003 2009 8649861 1:CAS:528:DyaK28XivF2ktLg%3D (Pubitemid 26154672)
55. DB O'Gorman J Weiss A Hettiaratchi SM Firth CD Scott 2002 Insulin-like growth factor-ii/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo Endocrinology 143 11 4287 4294 12399424 (Pubitemid 35239560)
56. M Pollak 2008 Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 12 915 928 nrc2536[pii]10.1038/nrc2536 19029956 1:CAS:528:DC%2BD1cXhsVWhu7rL
57. P Shier VM Watt 1989 Primary structure of a putative receptor for a ligand of the insulin family J Biol Chem 264 25 14605 14608 2768234 1:CAS:528:DyaK3cXitlWnsLc%3D (Pubitemid 19237270)
58. B Zhang RA Roth 1992 The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities J Biol Chem 267 26 18320 18328 1326521 1:CAS:528:DyaK38XmtVGrs78%3D
59. J Nakae Y Kido D Accili 2001 Distinct and overlapping functions of insulin and igf-i receptors Endocr Rev 22 6 818 835 11739335 1:CAS:528:DC%2BD38XltlOgsA%3D%3D (Pubitemid 34214297)
60. J Baker JP Liu EJ Robertson A Efstratiadis 1993 Role of insulin-like growth factors in embryonic and postnatal growth Cell 75 1 73 82 0092-8674(93)90680-O[pii] 8402902 1:CAS:528:DyaK3sXms1entLs%3D (Pubitemid 23306022)
61. DL Hadsell 2004 Genetic manipulation of mammary gland development and lactation Adv Exp Med Biol 554 229 251 15384580 1:CAS:528:DC%2BD2MXlvVCltLs%3D (Pubitemid 39304515)
62. I Torres-Aleman 2010 Toward a comprehensive neurobiology of igf-i Dev Neurobiol 70 5 384 396 10.1002/dneu.20778 20186710 1:CAS:528: DC%2BC3cXlvVKit7w%3D
63. S Humbert EA Bryson FP Cordelieres NC Connors SR Datta S Finkbeiner ME Greenberg F Saudou 2002 The igf-1/akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by akt Dev Cell 2 6 831 837 S1534580702001880[pii] 12062094 1:CAS:528:DC%2BD38XkslWqurk%3D (Pubitemid 34650078)
64. E Carro JL Trejo T Gomez-Isla D LeRoith I Torres-Aleman 2002 Serum insulin-like growth factor i regulates brain amyloid-beta levels Nat Med 8 12 1390 1397 10.1038/nm793nm793[pii] 12415260 1:CAS:528:DC%2BD38XptVSgsb0%3D (Pubitemid 36019424)
65. A Aleman HJ Verhaar EH De Haan WR De Vries MM Samson ML Drent EA Van der Veen HP Koppeschaar 1999 Insulin-like growth factor-i and cognitive function in healthy older men J Clin Endocrinol Metab 84 2 471 475 10022403 1:CAS:528:DyaK1MXhtVCit74%3D (Pubitemid 29075671)
66. M Llorens-Martin I Torres-Aleman JL Trejo 2009 Mechanisms mediating brain plasticity: igf1 and adult hippocampal neurogenesis Neuroscientist 15 2 134 148 15/2/134[pii]10.1177/1073858408331371 19307421 1:CAS:528:DC%2BD1MXks1Sitr0%3D
67. B Li M Setoguchi X Wang AM Andreoli A Leri A Malhotra J Kajstura P Anversa 1999 Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart Circ Res 84 9 1007 1019 10325238 1:CAS:528:DyaK1MXjtFCjtrs%3D (Pubitemid 29227680)
68. S Welch D Plank S Witt B Glascock E Schaefer S Chimenti AM Andreoli F Limana A Leri J Kajstura P Anversa MA Sussman 2002 Cardiac-specific igf-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice Circ Res 90 6 641 648 11934830 1:CAS:528:DC%2BD38XjtF2gsb0%3D (Pubitemid 34640881)
69. A Colao 2008 The gh-igf-i axis and the cardiovascular system: clinical implications Clin Endocrinol (Oxf) 69 3 347 358 CEN3292[pii]10.1111/j.1365-2265. 2008.03292.x 1:CAS:528:DC%2BD1cXhtFentb7J
70. MS Suleiman RJ Singh CE Stewart 2007 Apoptosis and the cardiac action of insulin-like growth factor i Pharmacol Ther 114 3 278 294 S0163-7258(07)00049- 6[pii]10.1016/j.pharmthera.2007.03.001 17499363 1:CAS:528:DC%2BD2sXmtVantrg%3D (Pubitemid 46843252)
71. HJ Arnqvist 2008 The role of igf-system in vascular insulin resistance Horm Metab Res 40 9 588 592 10.1055/s-0028-1082325 18792869 1:CAS:528: DC%2BD1cXhtlamtbzI
72. TJ Smith 2010 Insulin-like growth factor-i regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev 62 2 199 236 pr.109.002469[pii]10.1124/pr.109.002469 20392809 1:CAS:528: DC%2BC3cXhsVSltbnE
73. Y Higashi S Sukhanov A Anwar SY Shai P Delafontaine 2010 Igf-1, oxidative stress and atheroprotection Trends Endocrinol Metab 21 4 245 254 S1043-2760(09)00214-8[pii]10.1016/j.tem.2009.12.005 20071192 1:CAS:528:DC%2BC3cXksVejtb0%3D
74. VR Sara K Hall 1990 Insulin-like growth factors and their binding proteins Physiol Rev 70 3 591 614 1694588 1:CAS:528:DyaK3cXls1Gnt7c%3D (Pubitemid 20196044)
75. AB Pardee 1989 G1 events and regulation of cell proliferation Science 246 4930 603 608 2683075 1:CAS:528:DyaK3cXis12n
76. MN Pollak ES Schernhammer SE Hankinson 2004 Insulin-like growth factors and neoplasia Nat Rev Cancer 4 7 505 518 10.1038/nrc1387nrc1387[pii] 15229476 1:CAS:528:DC%2BD2cXlt1Oktro%3D (Pubitemid 38868620)
77. H Werner E Karnieli FJ Rauscher D LeRoith 1996 Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor i receptor gene Proc Natl Acad Sci USA 93 16 8318 8323 8710868 1:CAS:528:DyaK28XkvFylurw%3D (Pubitemid 26269555)
78. D LeRoith S Yakar 2007 Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1 Nat Clin Pract Endocrinol Metab 3 3 302 310 ncpendmet0427[pii]10.1038/ncpendmet0427 17315038 1:CAS:528: DC%2BD2sXjt1Smu7Y%3D
79. N Mauras MW Haymond 2005 Are the metabolic effects of gh and igf-i separable? Growth Horm IGF Res 15 1 19 27 S1096-6374(04)00172-8[pii]10.1016/j. ghir.2004.12.003 15701568 1:CAS:528:DC%2BD2MXhtFOltb0%3D (Pubitemid 40220851)
80. KC Yuen DB Dunger 2007 Therapeutic aspects of growth hormone and insulin-like growth factor-i treatment on visceral fat and insulin sensitivity in adults Diabetes Obes Metab 9 1 11 22 DOM591[pii]10.1111/j.1463-1326.2006. 00591.x 17199714 1:CAS:528:DC%2BD2sXitlCgsL8%3D (Pubitemid 44921037)
81. C Camacho-Hubner KA Woods AJ Clark MO Savage 2002 Insulin-like growth factor (igf)-i gene deletion Rev Endocr Metab Disord 3 4 357 361 12424437 (Pubitemid 41448829)
82. DR Clemmons AC Moses MJ McKay A Sommer DM Rosen J Ruckle 2000 The combination of insulin-like growth factor i and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity J Clin Endocrinol Metab 85 4 1518 1524 10770191 1:CAS:528:DC%2BD3cXisFOqurY%3D (Pubitemid 32289494)
83. DR Clemmons AC Moses A Sommer W Jacobson AD Rogol MR Sleevi G Allan 2005 Rh/igf-i/rhigfbp-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose Growth Horm IGF Res 15 4 265 274 S1096-6374(05)00055-9[pii]10.1016/j.ghir.2005.05.002 16005252 1:CAS:528:DC%2BD2MXntVGms7k%3D (Pubitemid 41093731)
84. K Cusi R DeFronzo 2000 Recombinant human insulin-like growth factor i treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance J Clin Endocrinol Metab 85 9 3077 3084 10999789 1:CAS:528:DC%2BD3cXmsVKrurY%3D
85. T Saukkonen F Shojaee-Moradie RM Williams R Amin KC Yuen A Watts CL Acerini AM Umpleby DB Dunger 2006 Effects of recombinant human igf-i/igf-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes Diabetes 55 8 2365 2370 55/8/2365[pii]10.2337/db05-1646 16873702 1:CAS:528:DC%2BD28Xot1Ogu7o%3D (Pubitemid 44743636)
86. RR Henry L Abrams S Nikoulina TP Ciaraldi 1995 Insulin action and glucose metabolism in nondiabetic control and niddm subjects. Comparison using human skeletal muscle cell cultures Diabetes 44 8 936 946 7622000 1:CAS:528: DyaK2MXnsVSntrg%3D
87. A Baudry B Lamothe D Bucchini J Jami D Montarras C Pinset RL Joshi 2001 Igf-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells FEBS Lett 488 3 174 178 S0014-5793(00)02435- 2[pii] 11163767 1:CAS:528:DC%2BD3MXhsVSrsLc%3D (Pubitemid 32103592)
88. K Sakai HB Lowman DR Clemmons 2002 Increases in free, unbound insulin-like growth factor i enhance insulin responsiveness in human hepatoma g2 cells in culture J Biol Chem 277 16 13620 13627 10.1074/jbc. M107771200M107771200[pii] 11834727 1:CAS:528:DC%2BD38XjsFWnsr4%3D (Pubitemid 34967961)
89. C Ohlsson S Mohan K Sjogren A Tivesten J Isgaard O Isaksson JO Jansson J Svensson 2009 The role of liver-derived insulin-like growth factor-i Endocr Rev 30 5 494 535 er.2009-0010[pii]10.1210/er.2009-0010 19589948 1:CAS:528: DC%2BD1MXhtFaisbnI
90. TM DeChiara A Efstratiadis EJ Robertson 1990 A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor ii gene disrupted by targeting Nature 345 6270 78 80 10.1038/345078a0 2330056 1:CAS:528:DyaK3cXktFyrsr0%3D (Pubitemid 20152456)
91. N Giannoukakis C Deal J Paquette CG Goodyer C Polychronakos 1993 Parental genomic imprinting of the human igf2 gene Nat Genet 4 1 98 101 10.1038/ng0593-98 8099843 1:CAS:528:DyaK3sXkt1aiu7Y%3D (Pubitemid 23165922)
92. H Ren P Yin C Duan 2008 Igfbp-5 regulates muscle cell differentiation by binding to igf-ii and switching on the igf-ii auto-regulation loop J Cell Biol 182 5 979 991 jcb.200712110[pii]10.1083/jcb.200712110 18762576 1:CAS:528:DC%2BD1cXhtFejtL3N
93. AE Reeve MR Eccles RJ Wilkins GI Bell LJ Millow 1985 Expression of insulin-like growth factor-ii transcripts in wilms' tumour Nature 317 6034 258 260 2995817 1:CAS:528:DyaL2MXmtVOru7g%3D (Pubitemid 16246502)
94. R Lammers A Gray J Schlessinger A Ullrich 1989 Differential signalling potential of insulin- and igf-1-receptor cytoplasmic domains EMBO J 8 5 1369 1375 2548842 1:CAS:528:DyaL1MXktFyjtbw%3D (Pubitemid 19274360)
95. RM Shymko E Dumont P De Meyts JE Dumont 1999 Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding Biochem J 339 Pt 3 675 683 10215607 1:CAS:528:DyaK1MXksFKrsb0%3D (Pubitemid 29243532)
96. A Louvi D Accili A Efstratiadis 1997 Growth-promoting interaction of igf-ii with the insulin receptor during mouse embryonic development Dev Biol 189 1 33 48 S0012-1606(97)98666-8[pii]10.1006/dbio.1997.8666 9281335 1:CAS:528:DyaK2sXlvFCns7w%3D (Pubitemid 27402461)
97. DC Mynarcik PF Williams L Schaffer GQ Yu J Whittaker 1997 Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding J Biol Chem 272 30 18650 18655 9228034 1:CAS:528:DyaK2sXltVSgsrk%3D (Pubitemid 27318207)
98. K Zelobowska J Gumprecht W Grzeszczak 2009 Mitogenic potency of insulin glargine Endokrynol Pol 60 1 34 39 19224503 1:CAS:528:DC%2BD1MXotlSitL4%3D
99. GP Schwartz GT Burke PG Katsoyannis 1987 A superactive insulin: [b10-aspartic acid]insulin(human) Proc Natl Acad Sci USA 84 18 6408 6411 3306677 1:CAS:528:DyaL2sXmt12gsLw%3D (Pubitemid 18002808)
100. KE Bornfeldt RA Gidlof A Wasteson M Lake A Skottner HJ Arnqvist 1991 Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities Diabetologia 34 5 307 313 1713869 1:CAS:528: DyaK3MXlvFyktr0%3D
101. K Drejer 1992 The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake Diabetes Metab Rev 8 3 259 285 1338040 1:CAS:528:DyaK3sXisVOks7o%3D
102. G Milazzo L Sciacca V Papa ID Goldfine R Vigneri 1997 Aspb10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-i receptor Mol Carcinog 18 1 19 25 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M[pii] 9022809 1:CAS:528:DyaK2sXhtVWrs7k%3D (Pubitemid 27107371)
103. BF Hansen GM Danielsen K Drejer AR Sorensen FC Wiberg HH Klein AG Lundemose 1996 Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency Biochem J 315 Pt 1 271 279 8670118 1:CAS:528:DyaK28XitlygtLk%3D (Pubitemid 26113562)
104. M Pollak D Russell-Jones 2010 Insulin analogues and cancer risk: cause for concern or cause celebre? Int J Clin Pract 64 5 628 636 IJCP2354[pii]10. 1111/j.1742-1241.2010.02354.x 20201993 1:CAS:528:DC%2BC3cXksVertbk%3D
105. M Bahr T Kolter G Seipke J Eckel 1997 Growth promoting and metabolic activity of the human insulin analogue [glya21, argb31, argb32]insulin (hoe 901) in muscle cells Eur J Pharmacol 320 2-3 259 265 S0014-2999(96)00903-X[pii] 9059862 1:STN:280:DyaK2s3htlSrsA%3D%3D (Pubitemid 27076754)
106. SI Chisalita HJ Arnqvist 2004 Insulin-like growth factor i receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells Am J Physiol Endocrinol Metab 286 6 E896 E901 10.1152/ajpendo.00327.200300327.2003[pii] 14722023 1:CAS:528: DC%2BD2cXkvFGjs7k%3D
107. TP Ciaraldi L Carter G Seipke S Mudaliar RR Henry 2001 Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and igf-i J Clin Endocrinol Metab 86 12 5838 5847 11739448 1:CAS:528:DC%2BD3MXptVylu7Y%3D (Pubitemid 33152632)
108. P Kurtzhals L Schaffer A Sorensen C Kristensen I Jonassen C Schmid T Trub 2000 Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 6 999 1005 10866053 1:CAS:528:DC%2BD3cXjvFylu7w%3D (Pubitemid 30349423)
109. A Shukla J Grisouard V Ehemann A Hermani H Enzmann D Mayer 2009 Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines Endocr Relat Cancer 16 2 429 441 ERC-08-0240[pii]10.1677/ERC-08-0240 19153208 1:CAS:528:DC%2BD1MXptlOht7c%3D
110. D Weinstein M Simon E Yehezkel Z Laron H Werner 2009 Insulin analogues display igf-i-like mitogenic and anti-apoptotic activities in cultured cancer cells Diabetes Metab Res Rev 25 1 41 49 10.1002/dmrr.912 19145584 1:CAS:528:DC%2BD1MXivFWjurg%3D
111. D Mayer E Chantelau 2010 Treatment with insulin glargine (lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on mcf-7 breast cancer cells Arch Physiol Biochem 116 2 73 78 10.3109/13813451003631439 20199195 1:CAS:528:DC%2BC3cXltF2rs7o%3D
112. L Berti M Kellerer B Bossenmaier E Seffer G Seipke HU Haring 1998 The long acting human insulin analog hoe 901: characteristics of insulin signalling in comparison to asp(b10) and regular insulin Horm Metab Res 30 3 123 129 10.1055/s-2007-978849 9566852 1:CAS:528:DyaK1cXitVClt7w%3D (Pubitemid 28172517)
113. K Staiger H Staiger MA Schweitzer E Metzinger B Balletshofer HU Haring M Kellerer 2005 Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells Diabetologia 48 9 1898 1905 10.1007/s00125-005-1874-4 16078017 1:CAS:528:DC%2BD2MXhtVSqtLzK (Pubitemid 41317846)
114. S Erbel C Reers VW Eckstein J Kleeff MW Buchler PP Nawroth RA Ritzel 2008 Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine Diabetes Care 31 6 1105 1111 dc07-2015[pii]10.2337/dc07-2015 18316392 1:CAS:528: DC%2BD1cXotVansbY%3D
115. K Staiger AM Hennige H Staiger HU Haring M Kellerer 2007 Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells Horm Metab Res 39 1 65 67 10.1055/s-2007-957352 17226117 1:CAS:528:DC%2BD2sXis1Wntr4%3D (Pubitemid 46535160)
116. E Liefvendahl HJ Arnqvist 2008 Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and igf-i Horm Metab Res 40 6 369 374 10.1055/s-2008-1062739 18393172 1:CAS:528:DC%2BD1cXpvVKksbw%3D (Pubitemid 351967126)
117. I Stammberger A Bube B Durchfeld-Meyer H Donaubauer G Troschau 2002 Evaluation of the carcinogenic potential of insulin glargine (lantus) in rats and mice Int J Toxicol 21 3 171 179 10.1080/10915810290096306 12055018 1:CAS:528:DC%2BD38XlsF2jurg%3D (Pubitemid 34803492)
118. K Eckardt C May M Koenen J Eckel 2007 Igf-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts Diabetologia 50 12 2534 2543 10.1007/s00125-007-0815-9 17898992 1:CAS:528:DC%2BD2sXht1Kku7jJ (Pubitemid 350060636)